Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18...

Press/Media

Period29 Feb 2024

Media coverage

1

Media coverage

  • TitleInterim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18...
    Media name/outletAfricanDiasporaLeaders.com
    Country/TerritoryUnited States
    Date29/02/24
    PersonsChristian Rogerson